Dr. Carey K. Anders, MD
Medical Director of the Brain and Spine Metastases Program
Translating Duke Health Scholar; Duke Cancer Institute Member
Duke University Medical Center
Dr. Carey K. Anders is the Medical Director of the Duke Brain and Spine Metastases Program and a member of the Neuro-Oncology (primary) and Breast Cancer (secondary) Programs within the Duke Cancer Institute. Dr. Anders is a leading expert in the clinical care of patients with breast cancer of all stages, with a research focus in breast cancer that spreads to the central nervous system (CNS). In her role at Duke, she is expanding her clinical and research focus to brain metastases arising from solid tumors, more globally, alongside a state-of-the-art multidisciplinary team. Prior to her arrival at Duke, Dr. Anders was an Associate Professor at the University of North Carolina at Chapel Hill were she established herself as a translational/clinical investigator. Over a decade at UNC, she focused on the biologic underpinnings of breast cancer brain metastases, was involved in many preclinical studies evaluating promising new therapies in models of breast cancer brain metastases, and designed, implemented, and completed numerous, novel clinical trials for patients with breast cancer brain metastases.
Dr. Anders earned her medical degree from the Brody School of Medicine at East Carolina University in 2002. She then completed her residency in Internal Medicine, followed by her fellowship in Hematology-Oncology at Duke University.
Following her training at Duke in 2008, she transitioned to the University of North Carolina at Chapel Hill where she served as the Lineberger Comprehensive Cancer Center (LCCC) Breast Cancer Program co-leader, the director of the LCCC Breast Cancer Clinical Trials Program, and Section Chief of Breast Medical Oncology. She was recruited back to Duke in January of 2019 where she currently serves as the Medical Director of the Brain and Spine Metastases Program. Among her accomplishments, she is a Translating Duke Health Scholar, and a recipient of a Damon Runyon Clinical Investigator Award, an NCI Mentored Research Scholar Grant, and the American Society of Clinical Oncology Advanced Clinical Research Award. She also serves of the co-leader of the Hoosier Cancer Research Network Breast Committee and is an active member of the Translational Breast Cancer Research Consortium.